FDA — authorised 28 February 1997
- Application: ANDA074767
- Marketing authorisation holder: AUROBINDO PHARMA LTD
- Status: approved
FDA authorised Serum on 28 February 1997
Yes. FDA authorised it on 28 February 1997; FDA authorised it on 30 July 1999; FDA has authorised it.
AUROBINDO PHARMA LTD holds the US marketing authorisation.